Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Do You Know Where Your Instruments Are? How Surgical Instrument Marking Can Improve Your Perioperative feat. Bill Camargo and Jennifer Bingaman

Ahead of any surgical procedure or operation is the preparation of surgical instruments. In the latest episode of the podcast “ConCensis,” host Tyler Kern discussed the ins and outs of how Censis utilizes its software to facilitate the use of surgical instruments throughout the full perioperative loop by putting marks on each individual instrument. He…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from Censis on MarketScale.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

Ahead of any surgical procedure or operation is the preparation of surgical instruments. In the latest episode of the podcast “ConCensis,” host Tyler Kern discussed the ins and outs of how Censis utilizes its software to facilitate the use of surgical instruments throughout the full perioperative loop by putting marks on each individual instrument. He spoke with Bill Camargo, Manager of Marking Services, and Jennifer Bingaman, Director of Business Services, on how Censis gets it right.

According to Camargo, there are three main types of surgical instrument markings commonly used – laser, electrochemical, and mechanical. Laser is the most popular, however, there are instances where one or more may be utilized together. For laser marking a significant amount of space is needed between the lens and instrument of marking, so that’s when electrochemical and mechanical marking come into play.

“With some instrument configurations, it’s very difficult, if not impossible, to mark it with a laser, that’s where electrochemical comes into play,” said Camargo. He went on to note that mechanical markings come through with a solution if the former two aren’t the best options. The downside to mechanical markings is their lack of permanence.

Marking allows the perioperative to be as smooth and clear as possible. It also makes the job of operating room (OR) staff members much smoother, particularly in critical times. Facilities choose to mark instruments to maintain efficient organization and tracking, according to Bingaman.

“There’s usually two main reasons why people choose to mark instruments, the biggest being that when you’re assembling a tray in sterile processing and you’re able to scan each instrument to that set, it helps ensure that you have a complete set to the OR, so that OR staff aren’t spending their time looking for missing instruments,” said Bingaman.

Surgical instrument marking also makes identifying and pinpointing the source of any issue that might arise during a procedure. While each surgical instrument tray is unique, when surgical instruments have markings, it clarifies a particular instrument giving you a deeper level of tracking information.

“If God forbid there’s an infection control issue, then if you have instruments marked and you’re scanning at instrument level, then you know exactly what instruments were used on that patient, rather than just knowing this tray was used on this patient. You actually get down to the instrument level,” said Bingaman.

Censis’s CensiTrac software adds another element that improves surgical instrument marking and tracking. Bingaman compared the tracking method to manufacturing barcodes. Similar to how barcodes identify what products were just scanned in a grocery store for example, entering surgical instrument data into the CensiTrac system will help it know what instrument is being used.

Interested in learning more about Censis Technologies’ surgical asset management platform? Visit Censis.com.

Censis

Part of this channel

Censis

Surgical instrument management software for over 1,300 U.S. hospitals.

Visit the channel

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Interchangeable biosimilars are getting approved faster, and Wezlana shows why

Interchangeable biosimilars are getting approved faster, and Wezlana shows why

The FDA approved Wezlana (ustekinumab-auub) as a biosimilar to and interchangeable with Stelara for multiple inflammatory diseases, which means it may be substituted without consulting the prescriber, subject to state pharmacy laws. A Springer analysis reported 26 interchangeable biosimilars approved since 2020 and said average approval timelines decreased from 798 days for applications dated in 2020 to 364 days for applications dated in 2024. The operational pressure shifts to formulary, payer, and specialty pharmacy workflow design.

  • 01Interchangeability is becoming the default ask, not an afterthought: Springer found 17 of 26 approvals pursued interchangeability concurrently, which changes how buyers should time contracting and conversions.
  • 02Springer reported average approval timelines decreased from 798 days for applications dated in 2020 to 364 days for applications dated in 2024, which can compress planning windows for monitoring and implementation.
  • 03A new interchangeable ustekinumab option means the hard work is no longer clinical, it is operational: NDC mapping, EMR preference lists, substitution rules by state, and patient communications decide whether savings show up.

Sep 8, 2026

AAO-HNSF hearing loss guideline moves audiograms and amplification into primary care

AAO-HNSF’s new age-related hearing loss guideline calls for screening adults starting at age 50 and escalating to otoscopy, audiogram, and appropriately fit amplification. It shifts hearing loss from “patient complaint” to a routine primary-care workflow. The pressure shows up in audiology capacity, referral design, and documentation standards.

  • 01Screening at age 50 becomes a repeatable workflow, so capacity planning shifts from episodic ENT referrals to steady primary-care volume, especially where annual wellness visits are a dominant access point.
  • 02The guideline’s escalation sequence, screen, otoscopy, audiogram, amplification, then cochlear implant candidacy evaluation, creates a measurable funnel that health systems can instrument in the EHR and manage like any other pathway.
  • 03Asymmetric loss remains a separate trigger for MRI in many settings, and 2026 pre-proof work using NHANES and SEER highlights why imaging criteria choices can swing scan volume, a budgeting and radiology access issue, not a clinical footnote.

Sep 7, 2026

ADHA shifts My Health Record to multi-supplier ops as Accenture signs new 3-year contract

ADHA shifts My Health Record to multi-supplier ops as Accenture signs new 3-year contract

Accenture will keep supporting Australia’s My Health Record under a new three-year contract. ADHA is moving the platform to a multi-supplier operating model. The shift raises questions about shared integration discipline, tooling, and accountability when changes hit production.

  • 01Multi-supplier delivery is spreading across national-scale health platforms, as ADHA's My Health Record shift shows, moving risk from vendor selection to integration, runbooks, and accountability.
  • 02GenAI model upgrades are arriving with healthcare-specific claims, but the procurement work moves to evidence, safety controls, and monitoring once models sit inside clinical workflows.
  • 03Embedded AI expands the cyber asset inventory problem: if teams cannot discover the AI components across endpoints and devices, they cannot reliably secure or audit them.

Sep 7, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512